Literature DB >> 23802878

Emergency department-based brief intervention to reduce risky driving and hazardous/harmful drinking in young adults: a randomized controlled trial.

Marilyn S Sommers1, Michael S Lyons, Jamison D Fargo, Benjamin D Sommers, Catherine C McDonald, Jean T Shope, Michael F Fleming.   

Abstract

BACKGROUND: Risky driving and hazardous drinking are associated with significant human and economic costs. Brief interventions for more than one risky behavior have the potential to reduce health-compromising behaviors in populations with multiple risk-taking behaviors such as young adults. Emergency department (ED) visits provide a window of opportunity for interventions meant to reduce both risky driving and hazardous drinking.
METHODS: We determined the efficacy of a Screening, Brief Intervention, and Referral to Treatment (SBIRT) protocol addressing risky driving and hazardous drinking. We used a randomized controlled trial design with follow-ups through 12 months. ED patients aged 18 to 44 who screened positive for both behaviors (n = 476) were randomized to brief intervention (BIG), contact control (CCG), or no-contact control (NCG) groups. The BIG (n = 150) received a 20-minute assessment and two 20-minute interventions. The CCG (n = 162) received a 20-minute assessment at baseline and no intervention. The NCG (n = 164) were asked for contact information at baseline and had no assessment or intervention. Outcomes at 3, 6, 9, and 12 months were self-reported driving behaviors and alcohol consumption.
RESULTS: Outcomes were significantly lower in BIG compared with CCG through 6 or 9 months, but not at 12 months: Safety belt use at 3 months (adjusted odds ratio [AOR], 0.22; 95% confidence interval [CI], 0.08 to 0.65); 6 months (AOR, 0.13; 95% CI, 0.04 to 0.42); and 9 months (AOR, 0.18; 95% CI, 0.06 to 0.56); binge drinking at 3 months (adjusted rate ratio [ARR] 0.84; 95% CI, 0.74 to 0.97) and 6 months (ARR, 0.81; 95% CI, 0.67 to 0.97); and ≥5 standard drinks/d at 3 months (AOR, 0.43; 95% CI, 0.20 to 0.91) and 6 months (AOR, 0.41; 95% CI, 0.17 to 0.98). No substantial differences were observed between BIG and NCG at 12 months.
CONCLUSIONS: Our findings indicate that SBIRT reduced risky driving and hazardous drinking in young adults, but its effects did not persist after 9 months. Future research should explore methods for extending the intervention effect.
Copyright © 2013 by the Research Society on Alcoholism.

Entities:  

Keywords:  Brief Intervention; Hazardous Drinking; Risky Driving

Mesh:

Year:  2013        PMID: 23802878      PMCID: PMC4106279          DOI: 10.1111/acer.12142

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  48 in total

1.  The impact of screening, brief intervention and referral for treatment in emergency department patients' alcohol use: a 3-, 6- and 12-month follow-up.

Authors: 
Journal:  Alcohol Alcohol       Date:  2010-09-27       Impact factor: 2.826

Review 2.  The alcohol use disorders identification test: an update of research findings.

Authors:  Duane F Reinert; John P Allen
Journal:  Alcohol Clin Exp Res       Date:  2007-02       Impact factor: 3.455

3.  Increased rural vehicular mortality rates: roadways with higher speed limits or excessive vehicular speed?

Authors:  Richard P Gonzalez; Glenn R Cummings; Herbert A Phelan; Shanna Harlin; Madhuri Mulekar; Charles B Rodning
Journal:  J Trauma       Date:  2007-12

4.  Effectiveness of alcohol screening and brief motivational intervention in the emergency department setting.

Authors:  Edward Bernstein; Judith Bernstein
Journal:  Ann Emerg Med       Date:  2008-04-23       Impact factor: 5.721

5.  The effects of text messaging on young drivers.

Authors:  Simon G Hosking; Kristie L Young; Michael A Regan
Journal:  Hum Factors       Date:  2009-08       Impact factor: 2.888

6.  Effects of a brief intervention for reducing violence and alcohol misuse among adolescents: a randomized controlled trial.

Authors:  Maureen A Walton; Stephen T Chermack; Jean T Shope; C Raymond Bingham; Marc A Zimmerman; Frederic C Blow; Rebecca M Cunningham
Journal:  JAMA       Date:  2010-08-04       Impact factor: 56.272

7.  Incidence and total lifetime costs of motor vehicle-related fatal and nonfatal injury by road user type, United States, 2005.

Authors:  Rebecca B Naumann; Ann M Dellinger; Eduard Zaloshnja; Bruce A Lawrence; Ted R Miller
Journal:  Traffic Inj Prev       Date:  2010-08       Impact factor: 1.491

8.  Effectiveness of brief interventions after alcohol-related vehicular injury: A randomized controlled trial.

Authors:  Marilyn S Sommers; Janice M Dyehouse; Steven R Howe; Michael Fleming; Jamison D Fargo; John C Schafer
Journal:  J Trauma       Date:  2006-09

9.  Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices.

Authors:  M F Fleming; K L Barry; L B Manwell; K Johnson; R London
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

10.  Societal costs of risky driving: an economic analysis of high-risk patients visiting an urban emergency department.

Authors:  Benjamin D Sommers; Jamison D Fargo; Michael S Lyons; Jean T Shope; Marilyn S Sommers
Journal:  Traffic Inj Prev       Date:  2011-04       Impact factor: 1.491

View more
  27 in total

1.  Management of Opioid Misuse and Opioid Use Disorders Among Youth.

Authors:  Camille A Robinson; J Deanna Wilson
Journal:  Pediatrics       Date:  2020-05       Impact factor: 7.124

2.  Examining motor vehicle crash involvement and readiness to change on drinking and driving behaviors among injured emergency department patients.

Authors:  Janette Baird; Eunice Yang; Valerie Strezsak; Michael J Mello
Journal:  Traffic Inj Prev       Date:  2016-12-06       Impact factor: 1.491

3.  Patient's lung cancer diagnosis as a cue for relatives' smoking cessation: evaluating the constructs of the teachable moment.

Authors:  Colleen M McBride; Michelle Blocklin; Isaac M Lipkus; William M P Klein; Thomas H Brandon
Journal:  Psychooncology       Date:  2015-10-30       Impact factor: 3.894

4.  Evaluation of a brief intervention to reduce the negative consequences of drug misuse among adult emergency department patients.

Authors:  Wentao Guan; Tao Liu; Janette R Baird; Roland C Merchant
Journal:  Drug Alcohol Depend       Date:  2015-10-13       Impact factor: 4.492

5.  Sex Differences in Substance Use Among Adult Emergency Department Patients: Prevalence, Severity, and Need for Intervention.

Authors:  Francesca L Beaudoin; Janette Baird; Tao Liu; Roland C Merchant
Journal:  Acad Emerg Med       Date:  2015-10-16       Impact factor: 3.451

6.  Goals-of-Care Conversations for Older Adults With Serious Illness in the Emergency Department: Challenges and Opportunities.

Authors:  Kei Ouchi; Naomi George; Jeremiah D Schuur; Emily L Aaronson; Charlotta Lindvall; Edward Bernstein; Rebecca L Sudore; Mara A Schonberg; Susan D Block; James A Tulsky
Journal:  Ann Emerg Med       Date:  2019-02-13       Impact factor: 5.721

7.  Estimating demand for primary care-based treatment for substance and alcohol use disorders.

Authors:  Colleen L Barry; Andrew J Epstein; David A Fiellin; Liana Fraenkel; Susan H Busch
Journal:  Addiction       Date:  2016-05-15       Impact factor: 6.526

8.  Risky driving, mental health, and health-compromising behaviours: risk clustering in late adolescents and adults.

Authors:  Catherine C McDonald; Marilyn S Sommers; Jamison D Fargo
Journal:  Inj Prev       Date:  2014-05-09       Impact factor: 2.399

9.  A feasibility test of a brief motivational interview intervention to reduce dating abuse perpetration in a hospital setting.

Authors:  Emily F Rothman; Na Wang
Journal:  Psychol Violence       Date:  2016-03-24

10.  Virtual reality job interview training in adults with autism spectrum disorder.

Authors:  Matthew J Smith; Emily J Ginger; Katherine Wright; Michael A Wright; Julie Lounds Taylor; Laura Boteler Humm; Dale E Olsen; Morris D Bell; Michael F Fleming
Journal:  J Autism Dev Disord       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.